The Y402H variant of complement factor H is associated with age-related macular degeneration but not with diabetic retinal disease in the Go-DARTS study

Diabetic Medicine

Volumn 26, Issue 5, 2009, Pages 460-465

  Doney, A S F ^b,c   Leese, G P ^b   Olson, J ^d   Morris, A D ^b   Palmer, C N A ^a,c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Population Pharmacogenetics Group   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Age related macular degeneration; Complement factor H; Diabetic retinopathy; Type 2 diabetes

Indexed keywords

COMPLEMENT FACTOR H;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE EXAMINATION; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINA MACULA AGE RELATED DEGENERATION;

AGED; AGED, 80 AND OVER; COMPLEMENT FACTOR H; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EPIDEMIOLOGIC METHODS; FEMALE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 65549091490     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02719.x     Document Type: Article

References (27)

1. Lotery A, Trump D. Progress in defining the molecular biology of age related macular degeneration. Hum Genet 2007 122 : 219 236. (Pubitemid 47616531)
2. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001 20 : 705 732. (Pubitemid 32918285)
3. Mullins RF, Johnson LV, Anderson DH, Hageman GS. Characterization of drusen-associated glycoconjugates. Ophthalmology 1997 104 : 288 294. (Pubitemid 27088105)
4. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 2001 73 : 887 896. (Pubitemid 34112114)
5. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 2000 70 : 441 449. (Pubitemid 30662042)
6. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006 38 : 458 462.
7. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, Wade MS et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 2006 38 : 1049 1054. (Pubitemid 44325931)
8. Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006 38 : 1055 1059. (Pubitemid 44325932)
9. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006 38 : 1173 1177. (Pubitemid 44470363)
10. Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol 2003 75 : 95 108. (Pubitemid 36798117)
11. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 2001 85 : 746 753. (Pubitemid 32554256)
12. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004 18 : 1450 1452. (Pubitemid 39561611)
13. Gerl VB, Bohl J, Pitz S, Stoffelns B, Pfeiffer N, Bhakdi S. Extensive deposits of complement C3d and C5b-9 in the choriocapillaries of eyes of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 2002 43 : 1104 1108. (Pubitemid 34258279)
14. Zhang J, Gerhardinger C, Lorenzi M. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes 2002 51 : 3499 3504. (Pubitemid 35403456)
15. Kastelan S, Zjacic-Rotkvic V, Kastelan Z. Could diabetic retinopathy be an autoimmune disease? Med Hypotheses 2007 68 : 1016 1018. (Pubitemid 46274046)
16. Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 2007 44 : 3901 3908. (Pubitemid 47337119)
17. Doggrell SA. Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration. Expert Opin Pharmacother 2005 6 : 1421 1423. (Pubitemid 41030899)
18. Krzystolik MG, Filippopoulos T, Ducharme JF, Loewenstein JI. Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy. Arch Ophthalmol 2006 124 : 920 921. (Pubitemid 43877695)
19. Leese GP, Morris AD, Swaminathan K, Petrie JR, Sinharay R, Ellingford A et al. Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Diabet Med 2005 22 : 1112 1115. (Pubitemid 41026013)
20. http://www.nsd.scot.nhs.uk/services/drs
21. Van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of ocular neovascularization: promises and potential problems. JAMA 2005 293 : 1509 1513. (Pubitemid 40393297)
22. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006 78 : 852 864.
23. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, De Maat MP et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006 296 : 301 309. (Pubitemid 44079314)
24. Schaumberg DA, Christen WG, Kozlowski P, Miller DT, Ridker PM, Zee RY. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 2006 47 : 2336 2340.
25. Mitchell P, Wang JJ. Diabetes, fasting blood glucose and age-related maculopathy: the Blue Mountains Eye Study. Aust NZ J Ophthalmol 1999 27 : 197 199. (Pubitemid 29429685)
26. Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004 111 : 1280 1287. (Pubitemid 38844822)
27. Zee RY, Diehl KA, Ridker PM. Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study. Atherosclerosis 2006 187 : 332 335. (Pubitemid 43963014)